Irenic Capital Management LP
13F filer · CIK 0001929389Reported Aug 14, 2026
Net buyer this quarter
13F portfolio value$2.08BU.S. long equity reported on 13F
Positions3914 new · 12 closed
Net flow last quarter+$184MBuys minus sells
Top 10 positions weight41.3%Concentration
Holdings
13F · last 4 quarters freeScroll for earlier quarters
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026Reported Aug 14, 202639 positions | |||||
| $133M | 6.40% | 1.74% | Not reported | Q1 2026 | |
| $128M | 6.15% | 1.55% | Not reported | Q4 2025 | |
| $118M | 5.67% | 3.72% | +0.1% | Q4 2025 | |
| $110M | 5.30% | 1.97% | Not reported | Q1 2026 | |
| $91.3M | 4.38% | 1.80% | +18.0% | Q4 2022 | |
| $77.7M | 3.73% | 4.02% | +56.1% | Q4 2025 | |
| $61.9M | 2.97% | 9.50% | +1.3% | Q2 2023 | |
| $48.5M | 2.33% | 2.50% | Not reported | Q1 2023 | |
| TBTBPHTheravance Biopharma, Inc. | $46.9M | 2.25% | 5.32% | Not reported | Q4 2022 |
| $43.2M | 2.07% | Not reported | New | Q2 2026 | |
| $41.2M | 1.98% | 0.56% | New | Q2 2026 | |
| $40.5M | 1.95% | 1.40% | -0.8% | Q3 2023 | |
| $38.6M | 1.85% | 1.50% | +3531.8% | Q4 2025 | |
| $37.6M | 1.81% | 0.91% | New | Q2 2026 | |
| $34.2M | 1.64% | 1.65% | Not reported | Q4 2025 | |
| $33.3M | 1.60% | 2.55% | -25.6% | Q1 2026 | |
| $28.5M | 1.37% | 1.58% | New | Q2 2026 | |
| $26.8M | 1.29% | Not reported | Not reported | Q3 2025 | |
| $26.2M | 1.26% | Not reported | Not reported | Q1 2025 | |
| $23.4M | 1.12% | 0.09% | +35.8% | Q4 2025 | |
| $23M | 1.10% | 0.03% | New | Q2 2026 | |
| $22.2M | 1.06% | 0.24% | New | Q2 2026 | |
| $20.9M | 1.00% | 0.58% | +217.5% | Q1 2026 | |
| $20.7M | 0.99% | 3.91% | -16.3% | Q1 2026 | |
| $15.7M | 0.75% | 0.51% | +46.2% | Q4 2025 | |
| $10.3M | 0.50% | 4.97% | Not reported | Q1 2025 | |
| $8.5M | 0.41% | 0.03% | New | Q2 2026 | |
| $8.05M | 0.39% | 1.93% | New | Q2 2026 | |
| WRWSRWhitestone REIT | $7.74M | 0.37% | 0.79% | -67.7% | Q4 2025 |
| GPGPACUGeneral Purpose Acquisition Corp. | $5.05M | 0.24% | Not reported | Not reported | Q4 2025 |
| $4.76M | 0.23% | 0.24% | New | Q2 2026 | |
| $4.15M | 0.20% | 0.98% | -72.2% | Q1 2023 | |
| $4.1M | 0.20% | 0.32% | New | Q2 2026 | |
| $3.91M | 0.19% | 0.97% | +3.6% | Q3 2023 | |
| $3.05M | 0.15% | Not reported | -33.3% | Q4 2025 | |
| $2.83M | 0.14% | 2.15% | Not reported | Q3 2025 | |
| $1.35M | 0.06% | 0.28% | New | Q2 2026 | |
| $668K | 0.03% | Not reported | New | Q2 2026 | |
| $52.5K | 0.00% | Not reported | Not reported | Q4 2025 | |
| Q1 2026Reported May 18, 202637 positions | |||||
| $138M | 8.99% | 1.72% | New | Q1 2026 | |
| $111M | 7.24% | 3.67% | Not reported | Q4 2025 | |
| $104M | 6.78% | 1.97% | New | Q1 2026 | |
| $72.4M | 4.71% | 1.56% | +424.1% | Q4 2025 | |
| $62.5M | 4.07% | 1.53% | +14.8% | Q4 2022 | |
| $60.5M | 3.94% | 9.42% | +3.3% | Q2 2023 | |
| TBTBPHTheravance Biopharma, Inc. | $44.8M | 2.92% | 5.36% | Not reported | Q4 2022 |
| $41.9M | 2.73% | 2.52% | +27.0% | Q1 2023 | |
| $39.3M | 2.56% | 2.58% | +1049.4% | Q4 2025 | |
| $36.3M | 2.36% | 1.38% | -25.4% | Q3 2023 | |
| $33.5M | 2.18% | 3.43% | New | Q1 2026 | |
| $33.3M | 2.17% | 1.63% | +32.2% | Q4 2025 | |
| $32.9M | 2.14% | Not reported | Not reported | Q3 2025 | |
| $20.6M | 1.34% | 3.89% | Not reported | Q2 2024 | |
| $20.5M | 1.33% | 3.56% | +29.3% | Q1 2023 | |
| WRWSRWhitestone REIT | $20.4M | 1.33% | 2.46% | +292.8% | Q4 2025 |
| $19.2M | 1.25% | 4.55% | New | Q1 2026 | |
| $18.7M | 1.22% | 0.06% | New | Q1 2026 | |
| $16.9M | 1.10% | Not reported | Not reported | Q4 2022 | |
| $15M | 0.98% | 2.01% | New | Q1 2026 | |
| $14.4M | 0.94% | 0.07% | +941.3% | Q4 2025 | |
| PRPKSTPeakstone Realty Trust | $14.1M | 0.92% | 1.81% | +100.3% | Q4 2025 |
| $14.1M | 0.92% | 4.97% | Not reported | Q1 2025 | |
| $10.6M | 0.69% | 1.26% | New | Q1 2026 | |
| $10.4M | 0.67% | 0.35% | +97.1% | Q4 2025 | |
| $8.48M | 0.55% | 0.54% | +740.2% | Q2 2025 | |
| GPGPACUGeneral Purpose Acquisition Corp. | $5.01M | 0.33% | Not reported | Not reported | Q4 2025 |
| $4.8M | 0.31% | 0.18% | New | Q1 2026 | |
| $3.84M | 0.25% | 2.15% | Not reported | Q3 2025 | |
| $3.75M | 0.24% | 0.89% | -29.2% | Q3 2023 | |
| $3.05M | 0.20% | Not reported | +50.0% | Q4 2025 | |
| $1.64M | 0.11% | 0.16% | New | Q1 2026 | |
| $1.62M | 0.11% | 0.38% | New | Q1 2026 | |
| $1.05M | 0.07% | 0.76% | New | Q1 2026 | |
| $823K | 0.05% | 0.04% | Not reported | Q4 2025 | |
| $583K | 0.04% | 0.06% | New | Q1 2026 | |
| $71.4K | 0.00% | 0.06% | Not reported | Q2 2024 | |
| Q4 2025Reported Feb 17, 202641 positions | |||||
| $99.1M | 6.67% | 3.68% | New | Q4 2025 | |
| $67M | 4.51% | 1.34% | +7.0% | Q4 2022 | |
| TBTBPHTheravance Biopharma, Inc. | $51.7M | 3.47% | 5.41% | Not reported | Q4 2022 |
| $48.6M | 3.27% | 1.99% | Not reported | Q1 2023 | |
| $47.6M | 3.20% | Not reported | +11.1% | Q3 2025 | |
| $45.3M | 3.05% | 9.13% | +5.6% | Q2 2023 | |
| $43.7M | 2.94% | 1.82% | +8.5% | Q3 2023 | |
| HHIHillenbrand, Inc. | $42.9M | 2.88% | 1.91% | Not reported | Q3 2025 |
| $40.3M | 2.71% | 1.21% | New | Q4 2025 | |
| $33.2M | 2.23% | 2.17% | +12.3% | Q3 2025 | |
| $30.7M | 2.07% | 3.93% | Not reported | Q2 2024 | |
| $23.1M | 1.55% | 2.78% | Not reported | Q1 2023 | |
| $17.6M | 1.18% | Not reported | Not reported | Q4 2022 | |
| $16.9M | 1.14% | 0.29% | New | Q4 2025 | |
| $16.7M | 1.13% | 4.97% | Not reported | Q1 2025 | |
| ADADArray Digital Infrastructure, Inc. | $12.6M | 0.85% | 0.27% | New | Q4 2025 |
| $12.5M | 0.84% | 0.99% | -69.7% | Q3 2025 | |
| $11.3M | 0.76% | Not reported | New | Q4 2025 | |
| $9.47M | 0.64% | 1.22% | Not reported | Q3 2023 | |
| CACWANClearwater Analytics Holdings, Inc. | $6.03M | 0.41% | Not reported | New | Q4 2025 |
| GPGPACUGeneral Purpose Acquisition Corp. | $5.01M | 0.34% | Not reported | New | Q4 2025 |
| PRPKSTPeakstone Realty Trust | $4.83M | 0.33% | 0.91% | New | Q4 2025 |
| $4.55M | 0.31% | 0.18% | New | Q4 2025 | |
| WRWSRWhitestone REIT | $4.48M | 0.30% | 0.63% | New | Q4 2025 |
| $3.46M | 0.23% | 0.57% | New | Q4 2025 | |
| $3M | 0.20% | Not reported | New | Q4 2025 | |
| $1.96M | 0.13% | 0.45% | New | Q4 2025 | |
| $1.83M | 0.12% | 0.01% | New | Q4 2025 | |
| $1.72M | 0.12% | 0.29% | New | Q4 2025 | |
| $1.46M | 0.10% | 0.01% | New | Q4 2025 | |
| $1.31M | 0.09% | 0.07% | -92.5% | Q2 2025 | |
| $1.23M | 0.08% | 0.01% | New | Q4 2025 | |
| $1.01M | 0.07% | 0.07% | New | Q4 2025 | |
| $884K | 0.06% | 0.04% | New | Q4 2025 | |
| $871K | 0.06% | 0.03% | Not reported | Q2 2025 | |
| $717K | 0.05% | 0.01% | New | Q4 2025 | |
| $302K | 0.02% | 0.00% | New | Q4 2025 | |
| $288K | 0.02% | 0.03% | New | Q4 2025 | |
| $262K | 0.02% | Not reported | +290.3% | Q2 2025 | |
| $46.4K | 0.00% | 0.01% | Not reported | Q1 2025 | |
| $40.5K | 0.00% | Not reported | New | Q4 2025 | |
| Q3 2025Reported Nov 14, 202517 positions | |||||
| $55.8M | 5.85% | 1.25% | -4.4% | Q4 2022 | |
| $51.7M | 5.42% | 3.27% | New | Q3 2025 | |
| $46.2M | 4.83% | 8.64% | +3.2% | Q2 2023 | |
| $42.8M | 4.48% | Not reported | New | Q3 2025 | |
| TBTBPHTheravance Biopharma, Inc. | $40.3M | 4.22% | 5.45% | Not reported | Q4 2022 |
| HHIHillenbrand, Inc. | $36.5M | 3.83% | 1.93% | New | Q3 2025 |
| $33.8M | 3.55% | 1.64% | -0.3% | Q3 2023 | |
| $31.5M | 3.30% | 3.94% | 0.0% | Q2 2024 | |
| $28.7M | 3.00% | 1.93% | New | Q3 2025 | |
| $24.5M | 2.57% | 0.88% | +339.7% | Q2 2025 | |
| $23.5M | 2.46% | 4.97% | Not reported | Q1 2025 | |
| $20.5M | 2.15% | Not reported | -7.8% | Q4 2022 | |
| $17.8M | 1.86% | 1.13% | -29.0% | Q2 2025 | |
| NSNSANational Storage Affiliates Trust | $12.2M | 1.28% | 0.52% | New | Q3 2025 |
| $3.04M | 0.32% | Not reported | New | Q3 2025 | |
| JJAMFJamf Holding Corp. | $963K | 0.10% | 0.07% | New | Q3 2025 |
| $59.3K | 0.01% | Not reported | Not reported | Q2 2025 | |
Premium opens every quarter this fund has filed